Cross Country Healthcare Inc (CCRN)

Currency in USD
13.25
+0.01(+0.08%)
Real-time Data·
Showing Cross Country historical data. For real-time data please try another search
Fair Value
Day's Range
13.2413.26
52 wk Range
7.4314.99
Key Statistics
Prev. Close
13.25
Open
13.25
Day's Range
13.24-13.26
52 wk Range
7.43-14.99
Volume
2.33M
Average Volume (3m)
773.65K
1-Year Change
-0.8975%
Book Value / Share
9.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CCRN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.44
Downside
-6.13%
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Analyst Ratings

0 Buy
7 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 12.44
(-6.13% Downside)

Cross Country Healthcare Inc SWOT Analysis


Merger Scrutiny
Delve into the complexities of Cross Country Healthcare's pending acquisition by Aya Healthcare, facing intense regulatory oversight and market skepticism
Financial Crossroads
Uncover Cross Country Healthcare's mixed financial performance, balancing declining core segments with growth in physician staffing and strong liquidity
Market Dynamics
Explore the evolving healthcare staffing landscape, from post-COVID demand shifts to increased M&A activity and labor movements shaping industry trends
Strategic Outlook
Analyze Cross Country Healthcare's potential paths forward, weighing merger benefits against regulatory risks and opportunities in expanding market segments
Read full SWOT analysis

Cross Country Healthcare Inc Earnings Call Summary for Q4/2025

  • Q4 2025 EPS of -$0.06 missed forecast by 400%; revenue of $236.76M fell 6.9% short, down 24% YoY amid healthcare staffing challenges.
  • Stock held steady at $8.98 post-earnings despite misses; company maintains strong balance sheet with zero debt and positive cash position.
  • Q1 2026 guidance projects revenue of $235-240M with adjusted EBITDA of $4-5M; expects adjusted EPS loss of $0.04-$0.06 per share.
  • Management cites market stabilization signs and continued AI/technology investments as growth drivers; gross margin held at 20.3% in Q4.
  • Key risks include 24% YoY revenue decline, travel nursing segment weakness, and dependence on successful technology integration for recovery.
Last Updated: 05/03/2026, 00:02
Read Full Transcript

Earnings

Latest Release
May 07, 2026
EPS / Forecast
-0.03 / -0.04
Revenue / Forecast
241.06M / 236.85M
EPS Revisions
Last 90 days

CCRN Income Statement

Compare CCRN to Peers and Sector

Metrics to compare
CCRN
Peers
Sector
Relationship
P/E Ratio
−4.3x12.4x−0.3x
PEG Ratio
0.010.000.00
Price/Book
1.4x1.9x2.6x
Price / LTM Sales
0.4x0.8x2.9x
Upside (Analyst Target)
0.0%−5.7%56.7%
Fair Value Upside
Unlock30.5%10.2%Unlock

People Also Watch

363.55
CIEN
+10.04%
35.09
VIAV
+8.87%
144.74
AVAV
+1.84%
9.689
INFQ
+9.72%
88.930
AAOI
+16.22%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.